## IVZ: Invesco Ltd - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.47 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: overbought RSI (72).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($25.38)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. A new partnership to help advisers rethink the possibilities of private markets**
- Source: Invesco | 20251209T050822 | Bullish | Relevance: 99%
-  Invesco has announced a new strategic partnership with LGT Capital Partners, a global specialist in alternative investing, to unlock new opportunities in private markets. This collaboration aims to provide financial advisers with multi-alternative private market solutions, initially focusing on the U.S. wealth and retirement channels. The partnership leverages the expertise and networks of both firms to offer enhanced growth, diversification, and innovation for investors.

**2. Key takeaways from our 2026 annual investment outlook webinar**
- Source: Invesco | 20251209T100943 | Bullish | Relevance: 99%
-  Invesco's 2026 Annual Investment Outlook webinar highlighted key opportunities and risks across various asset classes, including macro views, fixed income, equities, real estate, and alternatives. Experts anticipate continued economic resilience, a weakening US dollar, and growing interest in diversified equity strategies, particularly in Europe and emerging markets. The outlook also covers the potential of private markets, gold, and cryptocurrencies for diversification and inflation hedging.

**3. Eagle Materials Inc $EXP Shares Sold by Invesco Ltd.**
- Source: MarketBeat | 20251211T112500 | Neutral | Relevance: 99%
-  Invesco Ltd. reduced its stake in Eagle Materials Inc. (NYSE:EXP) by 47.3% in Q2, selling 311,780 shares, but still holds 1.07% of the company’s stock valued at $70.3 million. Despite missing EPS estimates, Eagle Materials reported revenue that slightly exceeded expectations and maintains strong profitability. The company's stock is currently rated as a "Hold" by analysts with an average target price of $243.30, and a director recently purchased 1,000 shares.

**4. Fitch Ratings: Invesco’s ‘A’ Rating Unaffected by $500MM Preferred Stock Redemption**
- Source: TradingView | 20251211T202533 | Neutral | Relevance: 99%
- Fitch Ratings views Invesco Ltd’s announced additional $500 million partial redemption of its outstanding perpetual series A preferred stock as neutral to its ‘A’ ratings. This transaction, following a $1 billion redemption earlier in the year, reduces total series A perpetual preferred stock outstanding to $2.5 billion. Fitch expects the transaction to have no material impact on Invesco's near-term leverage profile or interest coverage, maintaining conservative leverage policies and strong financial metrics commensurate with its current ratings.

**5. Invesco stock hits 52-week high at 27.3 USD**
- Source: Investing.com | 20251211T200613 | Bullish | Relevance: 99%
-  Invesco (IVZ) has reached a new 52-week high at $27.3 USD, reflecting robust investor confidence and a significant 52.75% increase over the past year. The asset management firm, with a market capitalization of $12.12 billion, also maintains a 3.12% dividend yield, though InvestingPro suggests it might be slightly overvalued. Recent activities include a slight decrease in AUM, a strategic partnership with LGT Capital Partners, and analyst target increases from BMO Capital and TD Cowen.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |
| 2025-11-25 | Goldman Sachs | $26 | $26 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | BMO Capital | main | Outperform |
| 2025-11-25 | Goldman Sachs | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($2.51M) |
| Sells | 5 ($4.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Insider selling cluster: $4.6M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.47 indicates undervaluation relative to growth. Forward P/E 10.8x attractive for 26% earnings growth. Quality metrics strong (margin 17%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 1.64 |
| 52W Range | $11.60 - $27.30 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.47 |
| Forward P/E | 10.8 |
| Current P/E | 13.6 |
| YoY Growth | 25.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 improving modestly (+0.7% over 5 days). Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 89th percentile. MRS_5 at 1.9% confirms short-term momentum alignment. AM_20 at 10.4% shows strong absolute momentum above own 20MA. Outperforming sector by 6.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.10% (CS: 89) | Strong |
| RSI_14 | 72.0 | Overbought |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.103x | Above |
| vs SMA50 | 1.131x | Above |
| vs SMA200 | 1.422x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $27.00
- **Stop Loss:** $25.38 (6.0% risk)
- **Target:** $30.24 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 851
- **Position Value:** $22,977.00
- **Portfolio %:** 22.98%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*